Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leif E Sander

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Nature Communications|November 25, 2023
Associations of myeloid cells with cellular and humoral responses following vaccinations in patients with neuroimmunological diseasesMeng Wang, Adeline Dehlinger, Camila Fernández Zapata, et al.
Journal of Travel Medicine|January 7, 2023
Post-treatment haemolysis is common following oral artemisinin combination therapy of uncomplicated malaria in travellersFlorian Kurth, Pinkus Tober-Lau, Tilman Lingscheid, et al.
Infection|April 14, 2022
Characterization of antimicrobial use and co-infections among hospitalized patients with COVID-19: a prospective observational cohort studyTilman Lingscheid, Lena J Lippert, David Hillus, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 5, 2022
Cutting Edge: Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4<sup>+</sup> T Cells following BNT162b2 Vaccination in the ElderlyLil Meyer-Arndt, Tatjana Schwarz, Lucie Loyal, et al.
Vaccine|January 16, 2022
A semisynthetic glycoconjugate provides expanded cross-serotype protection against Streptococcus pneumoniaePaulina Kaplonek, Ling Yao, Katrin Reppe, et al.
Journal of Global Antimicrobial Resistance|December 26, 2022
Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trialFlorian Kurth, Elisa T Helbig, Lena J Lippert, et al.
Molecular Therapy. Nucleic Acids|May 7, 2026
Lipid nanoparticle mRNA delivery preserves CAR T cell cytotoxicity and limits exhaustion compared to electroporationSamira Picht, Martí Farrera-Sal, Anna L Hiller, et al.
Nature Immunology|January 11, 2012
NLRC4 inflammasomes in dendritic cells regulate noncognate effector function by memory CD8⁺ T cellsAndreas Kupz, Greta Guarda, Thomas Gebhardt, et al.
BMJ Open|April 17, 2023
RECAST: Study protocol for an observational study for the understanding of the increased REsilience of Children compared to Adults in SARS-CoV-2 infecTionSebastian Stricker, Niklas Ziegahn, Martin Karsten, et al.
JCI Insight|March 7, 2023
Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19Charlotte Thibeault, Lara Bardtke, Kanika Vanshylla, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Nature Communications|November 25, 2023
Associations of myeloid cells with cellular and humoral responses following vaccinations in patients with neuroimmunological diseasesMeng Wang, Adeline Dehlinger, Camila Fernández Zapata, et al.
Journal of Travel Medicine|January 7, 2023
Post-treatment haemolysis is common following oral artemisinin combination therapy of uncomplicated malaria in travellersFlorian Kurth, Pinkus Tober-Lau, Tilman Lingscheid, et al.
Infection|April 14, 2022
Characterization of antimicrobial use and co-infections among hospitalized patients with COVID-19: a prospective observational cohort studyTilman Lingscheid, Lena J Lippert, David Hillus, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 5, 2022
Cutting Edge: Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4<sup>+</sup> T Cells following BNT162b2 Vaccination in the ElderlyLil Meyer-Arndt, Tatjana Schwarz, Lucie Loyal, et al.
Vaccine|January 16, 2022
A semisynthetic glycoconjugate provides expanded cross-serotype protection against Streptococcus pneumoniaePaulina Kaplonek, Ling Yao, Katrin Reppe, et al.
Journal of Global Antimicrobial Resistance|December 26, 2022
Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trialFlorian Kurth, Elisa T Helbig, Lena J Lippert, et al.
Molecular Therapy. Nucleic Acids|May 7, 2026
Lipid nanoparticle mRNA delivery preserves CAR T cell cytotoxicity and limits exhaustion compared to electroporationSamira Picht, Martí Farrera-Sal, Anna L Hiller, et al.
Nature Immunology|January 11, 2012
NLRC4 inflammasomes in dendritic cells regulate noncognate effector function by memory CD8⁺ T cellsAndreas Kupz, Greta Guarda, Thomas Gebhardt, et al.
BMJ Open|April 17, 2023
RECAST: Study protocol for an observational study for the understanding of the increased REsilience of Children compared to Adults in SARS-CoV-2 infecTionSebastian Stricker, Niklas Ziegahn, Martin Karsten, et al.
JCI Insight|March 7, 2023
Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19Charlotte Thibeault, Lara Bardtke, Kanika Vanshylla, et al.
Pageof 8